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Pseudomonas aeruginosa is known as an opportunistic pathogen that often causes
persistent infections associated with highly antibiotic-resistance and biofilms formation.
Chemical interference with bacterial cell-cell communication, termed quorum sensing
(QS), has been recognized as an attractive approach to control infections and address
the drug resistance problems currently observed worldwide. Instead of imposing direct
selective pressures on bacterial growth, the right bioactive compounds can preferentially
block QS-based communication and attenuate cascades of bacterial gene expression
and production of virulence factors, thus leading to reduced pathogenicity. Herein,
we report on the potential of itaconimides as quorum sensing inhibitors (QSI) of
P. aeruginosa. An initial hit was discovered in a screening program of an in-house
compound collection, and subsequent structure-activity relationship (SAR) studies
provided analogs that could reduce expression of central QS-regulated virulence factors
(elastase, rhamnolipid, and pyocyanin), and also successfully lead to the eradication of P.
aeruginosa biofilms in combination with tobramycin. Further studies on the cytotoxicity
of compounds using murine macrophages indicated no toxicity at common working
concentrations, thereby pointing to the potential of these small molecules as promising
entities for antimicrobial drug development.
Keywords: quorum sensing, biofilm, itaconimides, antivirulence, chemical biology
INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen and a major cause of nosocomical infections Q6
in patients with pneumonia, chronic wounds, urinary tract infections, and intensive care units
(ICUs) (Vincent et al., 1995). As an opportunistic pathogen, this organism is highly adaptive,
versatile and exhibits remarkable resistance toward many antimicrobial agents. Resistance is
a distinctive characteristic of P. aeruginosa, due to its ability to express multiple resistance
mechanisms, including enzymes and eﬄux pumps (Poole, 2001; Lister et al., 2009). (U.S. Centers
for Disease Control and Prevention (CDC), 2013) estimated that more than 20,000 deaths per year
are attributed to antibiotic resistance cases. It has become a global issue, and we are threatened with
the slow progress of new antibiotics development and lack of preventive measure for the spread of
resistance.
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In addition, P. aeruginosa is well-known to form biofilms,
which have been identified as a major underlying cause of
persistent infections in immunocompromised patients, chronic
wounds as well as on medical devices like implants, catheters,
tubes, artificial hip, and many more (Costerton et al., 1999).
Biofilms infections are often characterized by their broad
range resistance toward host defense mechanisms and antibiotic
therapy. This results in prolonged treatment, complications in
clinical outcomes, and additional socio-economic burdens. In
cystic fibrosis patients, chronic biofilm infections of P. aeruginosa
can cause premature death despite intensive antibiotic therapy
care (Bjarnsholt et al., 2009).
The bacteria in biofilms often exhibit different phenotypic and
genetic variants as compared to their planktonic counterparts.
In the biofilm mode of life, bacterial cells are enclosed within
a matrix of extracellular polymeric substances (EPS) comprises
of exopolysaccharides, proteins, deoxyribonucleic acid (DNA),
lipids or surfactants, and macromolecules that are self-produced
by the cells (Flemming and Wingender, 2010). All of these could
render antibiotics impenetrable, chelated or sequestered, and
diminish the efficacy of the treatment. The presence of persister
cells in biofilms also contributes to multidrug resistance property
of biofilms (Lewis, 2007). Overall, the complex biology of biofilms
represents a tremendous challenge to develop therapeutic agents
that could successfully prevent or eradicate biofilms-associated
infections.
The cell-to-cell communication system called quorum sensing
(QS) has been reported to play major roles for establishing
persistent, biofilm based infections (Hentzer et al., 2003; Alhede
et al., 2009; Van Gennip et al., 2009; Chiang et al., 2013). The
QS system in P. aeruginosa utilizes acyl homoserine lactones
(AHLs) as signal molecules and comprises the Lux homologs
LasRI and RhlRI. LasI synthase is responsible for the synthesis
of N-(3-oxododecanoyl) homoserine lactone (3-oxo-C12-HSL),
which will bind to its receptor LasR and activate transcription
of genes responsible for virulence such as lasB, apr, and toxA
(Gambello et al., 1993; Passador et al., 1993). The las system also
positively regulates rhl system, where RhlI directs the synthesis of
N-butanoylhomoserine lactone (C4-HSL) that would bind to its
receptor RhlR and subsequently activate gene expression of QS
target genes (Brint and Ohman, 1995; Pearson et al., 1995; Pesci
et al., 1997). In addition, there is also a third signaling molecule
“pseudomonas quinolone signal” (PQS) which is intertwined
between the las and rhl systems (Schertzer et al., 2009). Recently,
a fourth signal molecules called Integrative Quorum Sensing
Signal (IQS) has been reported, which could overtake the
central las system under phosphate depletion condition (Lee
et al., 2013). QS defective P. aeruginosa mutants are attenuated
as compared to the wild-type strain, and their biofilms are
more susceptible toward antibiotics treatment and host immune
system as compared to the wild-type (Pearson et al., 2000;
Hentzer et al., 2002, 2003).
As QS governs various patterns of genes expression to control
virulence and biofilm formation, it has been proposed that
interfering with the communication system could be a promising
strategy for the control and prevention of bacterial infections
(Hentzer et al., 2003). Quorum sensing inhibitors (QSI) are
compounds that interfere with QS pathways, reduce expression
of QS-controlled genes and attenuate infecting bacteria. As such
compounds do not affect the growth of bacteria, these molecular
entities pose lower selective pressure on bacteria and lower the
risk of resistance development. Recent exploration of new classes
of QSI comprises natural products, synthetic molecules, and
enzymes that may quench or inactivate QS signals (Dong et al.,
2001; Hentzer et al., 2002; Jakobsen et al., 2012; Fong et al., 2017).
Unfortunately, no clinical candidates have yet been developed for
therapy.
In the present study, we report a new class of small molecules
that disrupt QS pathways in P. aeruginosa. The structurally
related itaconimides and citraconimides have previously been
reported to inhibit growth of mycobacteria (Balganesh et al.,
1999). We synthesized a range of small molecules by an
iterative structure-activity relationship (SAR) study and found
two promising candidates for further biological investigation.
The efficacies of these compounds were tested on P. aeruginosa
QS bioreporter strains (lasB-gfp; rhlA-gfp; pqsA-gfp) and also on
QS-controlled virulence phenotypes, such as elastase, pyocyanin,
and rhamnolipid production.
MATERIALS AND METHODS
General Information
All chemicals were purchased from Sigma Aldrich and used Q8
without further purification. For biological studies, synthesized
compounds were prepared in DMSO as 10mM stock solution
and stored at −20◦C until further usage. Overnight culture of
bacteria was grown in Lysogeny broth (LB) which consisted
of 1% tryptone, 0.5% yeast extract, 0.5% NaCl. For bioreporter
assay, strains were grown in ABTGC (AB minimal medium
supplemented with 0.2% glucose and 0.2% casamino acids)
(Clark and Maaloe, 1967) to minimize fluorescence interference.
ABTG (with no casamino acid) medium was used for biofilms
study in flow chambers. Strains used in this study can be found
inTable 1. Summary of chemical synthesis and spectroscopy data
can be found in Supplementary Material.
Bioreporter QS Assay
From its frozen stock, compounds were diluted appropriately to
their working concentration in ABTGC medium. Experiments
were done as previously reported (Fong et al., 2017). Briefly, 200
µL of compounds was pipetted into the first rows of 96-well
plates (Nunc, Denmark), followed by two-fold serial dilution to
the rest of the rows. The last two rows were allocated to solvent
control (DMSO 0.1%) and blank (media control). Overnight
cultures of P. aeruginosa bioreporter strains were diluted to
optical density at 600 nm (OD600) of 0.02 (∼2.5× 10
8 CFU/mL).
Next, 100 µL of the bacteria culture was added into each well
to make final OD600 of 0.01. The plate was incubated at 37
◦C
for 16 h, with time-point measurement of GFP fluorescence
(excitation 485 nm, emission 535 nm) and OD600 recorded at
every 15min using Tecan Infinite 200 Pro plate reader (Tecan
Group Ltd, Männedorf, Switzerland). The data were exported
into excel files, and IC50 value calculation was determined using
GraphPad Prism 6 software. For IC50 values determination, the
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TABLE 1 | Bacterial strains used in this study.Q5
Strains or
plasmids
Relevant genotype and/or characteristicsa
Strains
PAO1 ATCC Pseudomonas aeruginosa Hentzer et al., 2002
PAO1-gfp GFP-tagged wild-type Pseudomonas aeruginosa Yang
et al., 2007
PAO1-lasB-gfp PAO1 containing lasB-gfp(ASV) reporter fusion
Hentzer et al., 2002
PAO1-rhlA-gfp PAO1 containing rhlA-gfp(ASV) reporter fusion
Yang et al., 2007
PAO1-pqsA-gfp PAO1 containing pqsA-gfp(ASV) reporter fusion
Yang et al., 2009
PAO1 1lasI1rhlI Gma; PAO1 lasI and rhlI mutant Hentzer et al., 2003
PAO1 1lasR PAO1 lasR mutant Hentzer et al., 2003
1lasR-rhlA-gfp PAO1 lasR mutant containing rhlA-gfp(ASV) reporter
fusion Tan et al., 2013
1lasR-pqsA-gfp PAO1 lasR mutant containing pqsA-gfp(ASV) reporter
fusion Tan et al., 2013
aDescription of the strains’ antibiotic resistance. Gm, gentamicin; Carb, carbenicillin
resistance.
GFP/OD600 values were taken at the time point between 4 and
6 h, where inhibition started to occur. All experiments were done
in triplicate manner and repeated at least twice to confirm the
results.
QS-Regulated Virulence Factor Assays
Elastase activity was measured using EnzChekElastase kit
(Invitrogen, USA), following the manufacturer’s instruction.
Rhamnolipid was extracted and quantified using method
reported by Koch et al. with modifications (Koch et al.,
1991). Briefly, overnight cultures of P. aeruginosa were diluted
into ABTGC medium (OD600 = 0.01), with and without the
presence of compounds (DMSO as control). Cultures were grown
overnight at 37◦C, 200 rpm. Rhamnolipid was extracted from
the supernatant with diethyl ether (twice), and organic fractions
were concentrated to yield yellowish-white solids. The solids were
re-suspended in deionized water and added with 0.19% (w/v)
orcinol in 50% H2SO4. It was then heated at 80
◦C for 20–30min
to give dark orange color. Absorbance was measured at 421 nm
and the values were normalized with cell density at OD600.
Pyocyanin was extracted from overnight culture of P. aeruginosa
grown in Kings Medium A Base [MilliQ water supplemented
with proteose peptone (20 g/L), potassium sulfate (10 g/L),
magnesium chloride, anhydrous (1.640 g/L), and glycerol (10%
v/v)]. Supernatants were collected and extracted with chloroform
and 0.2M HCl. The presence of pyocyanin would turn the HCl
solution into pinkish color. Absorbance was measured at 520 nm
and normalized with cell density OD600 values. Experiments were
done in triplicate manner and repeated at least twice to confirm
the results.
Biofilm Experiments
GFP-tagged P. aeruginosa were grown in ABTG medium
and flowed through flow chambers as previously described
(Sternberg and Tolker-Nielsen, 2006). Each flow chamber is
consisted of three-channel flow cells that were supplied with
a flow of medium and oxygen, while waste medium would be
directed into a waste flask. Briefly, overnight cultures were diluted
1,000 times in ABTG medium and injected into each channel for
1 h incubation time without flow. Next, the medium was allowed
to flow into the flow cells and the velocity was maintained at 0.2
mm/s using Cole-Palmer peristaltic pump. Biofilms were grown
for 72 h before treatment with compounds for further 48 h. To
visualize dead cells, 300 µL of propidium iodide (PI) stain was
injected into each flow cells. Biofilm images were taken with LSM
confocal laser scanning microscope (Carl Zeiss, Germany) at 20x
objective lens. Microscopy images were processed with IMARIS
software (Bitplane AG, Zurich, Switzerland). Experiments were
done in triplicate manner and repeated at least twice to confirm
the results.
Cytotoxicity Assay
Toxicity assay was done as previously reported (Fong et al.,
2017). Murine macrophage RAW264.7 cell lines were
grown in Dulbecco’s Modified Eagle’s Medium (DMEM,
Life Technologies), supplemented with 10% fetal bovine
serum (Gibco) at 37◦C and 5% CO2. The cells were passaged
into 96-well microplates, with each well containing 1 ×
104 macrophages. After 16 h, the cells were washed with
phosphate-buffered saline (PBS) and treated with compounds
at varying concentration in 100 µL DMEM. The plate was
incubated at 37◦C and 5% CO2 for further 16 h. Resazurin
was then added into each well to reach final concentration
of 10µM for cell viability measurement. The live cells would
be able to convert the dye to red color, whereby dead cells
would remain as blue color. Absorbance was taken at 595 nm
using Tecan Infinite 200 Pro plate reader (Tecan Group
Ltd, Männedorf, Switzerland). Experiments were done in
triplicate manner and repeated at least twice to confirm the
results.
RESULTS
Synthesis and SAR Study
Recently, we discovered that 3-methylene-1-
tetradecylpyrrolidine-2,5-dione (Table 2, 1a) displayed QSI
activity against P. aeruginosa QS reporter strain (carrying a
lasB-gfp fusion). Different variation on the left-hand side of
1a proved that the exo-cyclic double bond was essential for
its biological activity. This led us to focus on the synthesis
and biological evaluation of N-substituted itaconimide analogs
against P. aeruginosa (Scheme 1). The procedure for the
synthesis of the itaconimides have been described by Cava
et al. (1961) and Leow et al. (2008). The commercially available
itaconic anhydride was treated with anilines (1.0 equiv.)
in CHCl3 to afford the corresponding α-itaconamic acids
(Kyung et al., 1974). The resulting acids were subsequently
treated with Ac2O (3.5 equiv.) and NaOAc (0.5 equiv.) at
elevated temperature to afford a mixture of itaconimide and
the isomerized product citraconimide. Generally, the yield for
the aniline derivatives was higher than that of the aliphatic
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TABLE 2 | Summary of the synthesized compounds and the corresponding yields.
Compound R a (%)a b (%)a Compound R a (%)a b (%)a
1 50 14 10 35 15
2 37 –b 11 61 9
3 17 –b 12 37 20
4 10 –b 13 40 19
5 47 –b 14 8 14
6 49 29 15 16 –b
7 –c 16 13 10
8 31 40 17 4 12
9 24 14 18 2 11
aYields based on starting itatonic anhydride and purified after cyclization by flash column chromatography.
bNot isolated.
cCommercial sample.
amines. An overview of the synthesized compounds is provided
below (Table 2).
QSI Activities of Itaconimides
The synthesized compounds were tested for their QS inhibitory
activity against the P. aeruginosa lasB-gfp reporter strain. None
of our synthesized compounds showed antibiotic properties
(Supplementary Figures 1, 2). We found that both the p-
bromophenyl and tetradecyl-substituted itaconimide (12a and
18a) showed strong QS inhibition activity against the lasB-
gfp reporter strain (Figure 1A). Both compounds inhibit the
expression of lasB-gfp in a dose-dependent manner (Figure 1B).
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SCHEME 1 | Synthesis of itaconimides and citraconimides.
18a was proved to be the most active compound synthesized in
this series, with almost 25-fold higher activity (IC50) compared
to our hit compound (Figures 1C,D).
To address the specificity of our compounds, we also tested
our compounds against PAO1 wild-type (WT) and 1lasR
harboring either rhlA-gfp or pqsA-gfp fusions. In this case, we
would be able to determine if the compounds could affect
other QS pathways in las-dependent or independent manner.
Both rhlA and pqsA are the first genes of rhl operon and pqs
operon that code for the production of the rhamnolipid and
PQS precursor molecules (Ochsner et al., 1994; Gallagher et al.,
2002). To eliminate false positive, we also tested both compounds
with a gfp-tagged P. aeruginosa (expresses GFP constitutively) as
control and did not observe any reduction in the fluorescence
signals (Supplementary Figure 3).
Compounds 12a and 18a were found to inhibit expression
of rhlA-gfp and pqsA-gfp in PAO1 WT. IC50 values calculated
for 12a are 6.67 ± 0.27µM for rhlA-gfp and 2.51 ± 0.19µM
for pqsA-gfp, whereby compound 18a provides IC50 values of
0.61 ± 0.04µM for rhlA-gfp and 0.143 ± 0.13 for pqsA-gfp
(Figure 2). At 10µM, compound 12a was observed to inhibit
rhlA-gfp more strongly in 1lasR (78% inhibition) as compared
to the wild-type (58% inhibition). In 1lasR pqsA-gfp reporter
strain, the inhibition only happened in the later stage.Meanwhile,
compound 18a was found to inhibit both rhlA-gfp and pqsA-
gfp efficiently in 1lasR (Figure 3). Therefore, it is likely that
two compounds have different mechanisms, and compound 18a
affect multiple QS pathways in las-independent pathway.
Effects of Itaconimides on Virulence
Production
Next, we investigated the effects of synthesized compounds on
virulence factors produced by P. aeruginosa, notably elastase,
rhamnolipid, and pyocyanin. The three virulence factors are
under QS-regulation, therefore they could be a good indicator
for evaluating antivirulence activities of our compounds. We
also included QS mutants as control strains, where they are
defective in producing quorum sensing signals hence lower
level of virulence production. At 10µM, both compounds were
able to reduce all three virulence factors production. Elastase
level was reduced almost half, and rhamnolipid and pyocyanin
productions were abolished almost to the same level as mutant
strains (Figure 4). The results showed that both compounds
could indeed lower the production of virulence factors.
Effects of Itaconimides on P. aeruginosa
Biofilms
QS has been shown to play important roles in biofilms matrix
formation (Davey et al., 2003; Sakuragi and Kolter, 2007).
Mutants lacking QS often form flat and undifferentiated biofilms
that could be easily cleared by antimicrobial agents and host
immune system (Wu et al., 2001; Christensen et al., 2007).
Here, we investigated if the itaconimides could eradicate biofilms
formation when used in combination with tobramycin antibiotic.
From Figure 5, it can be seen that treatment with tobramycin
alone (10µg/ml) couldn’t clear the whole population of P.
aeruginosa biofilms. The dead cells only appeared on the
surface of the biofilms, which indicated that the antibiotic
could not penetrate into the biofilms. In addition, biofilms
often contain extracellular DNA (eDNA) which could chelate
aminoglycoside antibiotics and render it inactive (Chiang et al.,
2013). At 10µM, itaconimide 12a could remarkably kill the
base population of the biofilms, but not the surface. When
added together with tobramycin, the combination treatment
successfully eradicated the whole population of biofilms, which
appeared red. Compound 18a did not show any synergistic effect
when used together with tobramycin, which could be due to poor
solubility in the aqueous media.
Cytotoxic Effects of Itaconimides on
Macrophages
We next evaluated the potential application of compounds
12a and 18a for therapeutic application. To test the cytotoxic
effects, both compounds were added into murine macrophage
RAW2647 cell lines, and the cell viability was measured after
16 h incubation time. Both compounds were observed to be
toxic at 40µM, but not cytotoxic at their working concentration
(10µM and lower, Figure 6). This indicates that they could be
further used for subsequent in vivo experiments at their relevant
concentration.
DISCUSSION
In this study, we present the investigation of itaconimides
as a novel QSI against P. aeruginosa. The approach of
using QSI molecules to attenuate the virulence of pathogenic
bacteria has advantages over conventional antibiotics therapy.
Instead of targeting the growth of bacteria (bactericidal or
bacteriostatic strategies), QSI compounds pose lesser selective
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FIGURE 1 | (A) Effects of compounds 12a and 18a on PAO1-lasB-gfp reporter strain. DMSO 0.1% was used as solvent control. (B) Dose-response effects ofQ4
Q5 compounds on P. aeruginosa lasB-gfp. (C) IC50 values of 12a and 18a (D) on lasB-gfp. Calculation was done using GraphPad Prism 6 software, taken at time point
between 4 and 6 h when QS inhibition started to occur. All experiments were done in triplicate manner (technical and biological replicates), only representative data are
shown.
FIGURE 2 | QSI inhibition, dose-response and IC50 values of compounds 12a and 18a on P. aeruginosa rhlA-gfp (A) and pqsA-gfp (B). DMSO 0.1% was used as
solvent control. For the IC50 values, calculation was done using GraphPad Prism 6 software, taken at time point between 4 and 6 h when QS inhibition started to
occur. All experiments were done in triplicate manner (technical and biological replicates), only representative data are shown.
pressure for the development of resistant mutants. In several
studies, it has been shown that mice treated with QSI
afford better survival profile and lower bacteria count loads
when compared to the control group (Hentzer et al., 2002,
2003; Jakobsen et al., 2013; Fong et al., 2017). With limited
options of treatment available, antivirulence therapy could be
a viable approach to mitigate the future crisis of antibiotic
resistance.
In this study, a structure-activity relationship (SAR) study
was performed to investigate the QSI activities of itaconimides
and citraconimide analogs. We screened the compounds against
QS reporter strain lasB-gfp, where gene expression is under
control of the QS las system. We first investigated the inhibitory
properties of the two isomers with respect to lasB-gfp expression.
Interestingly, the itaconimide scaffold was found to be more
active than the citaconimide. Next, we investigated the influence
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FIGURE 3 | QSI inhibition of compounds 12a and 18a on PAO1 1lasR rhlA-gfp (A) and pqsA-gfp (B). DMSO 0.1% was used as solvent control. All experiments were
done in triplicate manner (technical and biological replicates), only representative data are shown.
FIGURE 4 | Effects of compounds 12a and 18a on elastase (A), rhamnolipid (B), and pyocyanin production (C). Compounds were tested at final concentration of
10µM. All experiments were done in triplicate manner (technical and biological replicates). Error bars are means ± SDs. ****p < 0.0001, Student’s t-test.
FIGURE 5 | P. aeruginosa biofilms formed on flow cells for 72 h, followed by treatment with medium containing antibiotic (tobramycin 10µg/ml) and compounds
(10µM) for further 48 h. Live cells are P. aeruginosa tagged with GFP which appeared as green, and dead cells appeared as red. Scale bars, 50µm. Experiments
were done in triplicate manner (technical and biological replicates), only representative images were shown.
of electron donating groups (EDGs) and electron withdrawing
groups (EWGs) on the phenyl group. Whereas, p-anisidine
moiety failed to improve activity, the more electron-withdrawing
4-chloro derivative induced a 1.4-fold inhibition of PAO1-lasB-
gfp. This guided us to explore anilines with different EWGs.
The most potent compound in this series was 12a from 4-
bromoaniline that results in a 4.4-fold increase over the parent
aniline analog. To our surprise, the 4-fluoroaniline analog 13a
did not afford a more potent inhibitor. Alongside the findings
that 4-bromoaniline provided a more potent analog, we also
found that the octylamine analog 14a was more active than our
hit compound 1a. Lastly, we also included aliphatic chains to
mimic the long alkyl chain of C4-HSL and 3-oxo-C12-HSL. On
this note, a second series was synthesized from commercially
available aliphatic amines with variating carbon lengths (n =
4, 6, 8, 10, 12, 14). A clear trend was observed, where longer
alkyl chain resulted in lower IC50 values. The outcome was quite
interesting, as IC50 values of the citraconimide substituents of
these analogs (16b, 17b, and 18b) were significantly lowered.
The most potent compound was found to be the tetradecylamine
analog, 18a, being the most active of both series. By substituting
the naphthalene group with either 4-bromoaniline or long
chain alkyl amines, IC50 values against PAO1-lasB-gfp were
significantly reduced to the low micromolar range (2.41 ±
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FIGURE 6 | Cytotoxic effect of compounds 12a and 18a on murine
macrophages. DMSO was used as vehicle control. Compounds were tested
at various concentrations (40µM and subsequent 2x dilution). Experiments
were done in triplicate manner (technical and biological replicates). Error bars
are means ± SDs.
0.99µM for 12a and 0.17 ± 0.04µM for 18a). In summary,
our SAR studies revealed two structurally important variations
for the itaconimides that are highly important for QSI activity
(Table 3).
Previous studies have emphasized the advantage of
therapeutics that suppress multiple QS pathways (Fong et al.,
2018). Indeed, lasR mutants are commonly found in patients
suffering from cystic fibrosis and other clinical setting (Hamood
et al., 1996; Cabrol et al., 2003; Marvig et al., 2014). Nevertheless,
the loss-of-function lasRmutants continuously express virulence
traits so P. aeruginosa could use other pathways to bypass LasR
in controlling pathogenicity (Dekimpe and Déziel, 2009; Lee
et al., 2013). Using different QS reporter strains in both PAO1
WT and 1lasR, it can be deduced that our compounds do not
specifically inhibit one QS pathway. Both compounds could
inhibit expression of rhlA-gfp and pqsA-gfp in lasR mutant. The
inhibition of pqsA-gfp in 1lasR was less apparent for compound
12a, which could indicate that the compound inhibits PQS
system through las-dependent manner. The itaconimide analogs
presented here hold unique potential as broad target QSIs to
control infections via an anti-virulence strategy. Future work will
aim to elucidate the mechanism on how both compounds inhibit
QS in P. aeruginosa.
Next, we also tested the effects of our compounds on
the production of various virulence factors, such as elastase,
rhamnolipid, and pyocyanin production. Elastase is one of the
major proteases produced by P. aeruginosa, involved in host
tissue damage and host immune responses (Kamath et al., 2002).
Rhamnolipid is also an essential virulence factor and plays several
key roles in biofilms formation, swarming, and in particular
host immune evasion. It promotes rapid necrotic killing of
polymorphonuclear (PMNs) leukocytes and also infiltration of
respiratory epithelial cells (Zulianello et al., 2006; Jensen et al.,
2007). P. aeruginosa also secretes pyocyanin, blue redox-active
secondary metabolite that has several deleterious effects on
mammalian cells (Lau et al., 2004), which is also regulated by QS
under pqs system. When tested at 10µM, the compounds could
TABLE 3 | Summary of IC50 values of itaconimide (a) and citraconimide (b)
analogs against PAO1-lasB-gfp.
Compound a b
1 7.37 ± 0.71 –
2 23.52 ± 0.81 –
3 10.27 ± 0.05 –
4 – –
5 17.95 ± 0.49 –
6 10.67 ± 0.49 –
7 – NA
8 7.45 ± 0.65 –
9 7.65 ± 0.37 –
10 6.53 ± 0.61 –
11 17.68 ± 0.16 –
12 2.41 ± 0.99 –
13 11.89 ± 0.34 –
14 26.66 ± 0.98 –
15 1.71 ± 0.34 –
16 0.30 ± 0.05 2.01 ± 0.39
17 0.30 ± 0.17 0.91 ± 0.20
18 0.17 ± 0.04 0.53 ± 0.12
All IC50 values were reported as µM. Experiments were done in triplicate manner and
repeated at least twice to confirm the results. NA, Not available.
reduce production of various virulence factors controlled by QS.
This shows potential of our compounds as antivirulence agent of
P. aeruginosa.
P. aeruginosa biofilms are highly resistant to most antibiotics,
including the last-resort polymyxin antibiotic available, colistin
(Chua et al., 2016). As QS has definite role in biofilms
development, it has been proposed that QSI compounds could
be used as prophylactic treatment for biofilms infections. One
such case is using azithromycin, which inhibits QS and biofilm
formation at sub-MIC concentration. Promising results were
observed in pulmonary infections and CF patients in many
clinical trials data upon treatment of low-dose of AZM (2µg/ml)
(Hansen et al., 2005; Fleet et al., 2013). In this study, we utilized
a combination of our compounds with the aminoglycoside
tobramycin to treat P. aeruginosa biofilms grown on flow
chambers for 3 days. We chose to study tobramycin because
of its clinical relevance to cystic fibrosis (CF) patients. The
clinical isolates from lung patients often confer resistance to
aminoglycoside antibiotics (Hurley et al., 1995; Saiman et al.,
1996). Our data also shows that treatment with tobramycin alone
only kills the upper layer of biofilms. Combined with 12a, we
observed that the whole population of biofilms was eradicated.
The results offer promising application of QSI in combination
with antibiotics as a control for biofilm-associated infections.
It has been reported that stringent response, which provides
rapid adaptation to environmental stresses, regulates QS network
and also bacteria’s survival in biofilms of P. aeruginosa (van
Delden et al., 2001; Nguyen et al., 2011; Schafhauser et al., 2014).
QS-deficient mutants also have lower catalase and superoxide
dismutase activities, and therefore more sensitive to oxidative
stress (Hassett et al., 1999). Through our biofilms experiment, we
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could observe some cells death upon treatment with compound
12a in the base of the biofilms. This raises the possibility that our
compound could also target stringent response and other stress-
response genes, which resulted in the observed killing effect.
For compound 18a, it contains long alkyl chain, which may
render its solubility and penetration into the biofilms matrix.
Future study will investigate how our compounds could synergize
with other antibiotics to treat biofilms from other clinical
isolates.
Lastly, we investigated the cytotoxic profile of our compounds
onmacrophages. The cytotoxicity of the compounds is important
if they are to be used in animal studies for subsequent drug
development. Results indicated that compound 12a and 18a
are not toxic up to 40µM concentration. Still, further studies
are needed to qualify the efficacy of the compounds in mice
models for their potential as anti-biofilm agents, as well as their
pharmacodynamic and pharmacokinetic profiles.
In conclusion, we report the novel use of itaconimides as
antivirulence compounds for P. aeruginosa. These compounds
suppress the las, rhl, and pqs QS systems of P. aeruginosa, and
effectively abolish virulence expression activities. Compounds
12a and 18a showed low micromolar IC50 values against all three
QS reporter strains with only little toxicity against macrophages
at the administrated concentration. Moreover, a synergistic effect
with tobramycin was observed for the killing of P. aeruginosa
biofilms, including otherwise the tolerant and hard to target sub-
population cells. Overall, our findings point to a new class of hit
compounds of relevance to the development of new drugs against
the superbug P. aeruginosa.
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